Boule Diagnostics AB has decided to publish the interim report for the first six months of 2017 earlier than previously announced. The new publishing date is Friday, August 25 at 08:45.
For further information, please contact:
Fredrik Dalborg, CEO and President, Boule Diagnostics AB, phone +46 705-58 51 05
About Boule Diagnostics AB (publ)
Boule Diagnostics AB is a rapidly growing global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden and the USA. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011. http://www.boule.se
The information was submitted for publication, through the agency of the contact person set out above, at 11:15 August 23, 2017